XML 28 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
12. Segment Information (Tables)
 9 Months Ended
Sep. 30, 2013
Segment Reporting [Abstract]  
Information regarding industry segments
Information regarding industry segments for the three months ended September 30, 2013 and 2012 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2013
$
162.9

 
$
338.8

 
$
3.4

 
2012
$
167.0

 
$
328.4

 
$
3.3

 
 
 
 
 
 
 
Segment (loss) profit
2013
$
(8.5
)
 
$
43.0

 
$
—

 
2012
$
6.8

 
$
48.2

 
$
—


Information regarding industry segments for the nine months ended September 30, 2013 and 2012 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2013
$
489.5

 
$
1,030.2

 
$
10.4

 
2012
$
484.2

 
$
999.6

 
$
11.6

 
 
 
 
 
 
 
Segment (loss) profit
2013
$
(28.9
)
 
$
130.6

 
$
0.3

 
2012
$
9.4

 
$
151.8

 
$
1.8
Reconciliation of segment profit to consolidated income before taxes
The following reconciles total segment profit to consolidated (loss) income before taxes (in millions):

 
Three Months Ended
 
Nine Months Ended
 
September 30,
 
September 30,
 
2013
 
2012
 
2013
 
2012
Total segment profit
$
34.5

 
$
55.0

 
$
102.0

 
$
163.0

Foreign exchange losses, net
(3.3
)
 
(0.4
)
 
(5.7
)
 
(3.5
)
Net corporate operating, interest and other expense not allocated to segments
(37.1
)
 
(1.1
)
 
(39.1
)
 
(3.5
)
Other income (expense), net
0.7

 
1.5

 
10.7

 
14.7

Consolidated (loss) income before income taxes
$
(5.2
)
 
$
55.0

 
$
67.9

 
$
170.7